Search Results - D. A. Napalkov

Refine Results
  1. 1
    Russian Trial ALGORITHM: Implementation of Combined Antihypertensive and Hypolipidemic Treatment for Clinical Efficacy Achievement in Routine Clinical Practice

    Russian Trial ALGORITHM: Implementation of Combined Antihypertensive and Hypolipidemic Treatment for Clinical Efficacy Achievement in Routine Clinical Practice by D. A. Napalkov

    Published 2020-01-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW

    THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW by D. A. Napalkov

    Published 2015-09-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    STROKE PREVENTION IN INTERNIST PRACTICE

    STROKE PREVENTION IN INTERNIST PRACTICE by D. A. Napalkov, A. V. Zhilenko

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    MANAGEMENT OF PATIENT WITH ARTERIAL FIBRILLATION: WHAT`S NEW?

    MANAGEMENT OF PATIENT WITH ARTERIAL FIBRILLATION: WHAT`S NEW? by D. A. Napalkov, A. A. Sokolova

    Published 2016-12-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy

    Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy by D. A. Napalkov, A. A. Sokolova

    Published 2019-09-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    ACE inhibitor zofenopril effectiveness in arterial hypertension treatment

    ACE inhibitor zofenopril effectiveness in arterial hypertension treatment by D. A. Napalkov, E. N. Golovenko

    Published 2008-12-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    The rational approach to selection of anticoagulation for stroke prevention in patients with atrial fibrillation of non-valvular etiology

    The rational approach to selection of anticoagulation for stroke prevention in patients with atrial fibrillation of non-valvular etiology by D. A. Napalkov, A. A. Sokolova

    Published 2014-03-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Atrial Fibrillation: a Marker or Risk Factor for Stroke

    Atrial Fibrillation: a Marker or Risk Factor for Stroke by B. A. Tatarsky, D. A. Napalkov

    Published 2023-03-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL

    CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL by D. A. Napalkov, E. N. Golovenko

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol

    Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol by V. I. Makolkin, D. A. Napalkov

    Published 1970-01-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Optimal treatment strategies in comorbid patients with hypertension and dyslipidemia: the role of fixed-dose combinations

    Optimal treatment strategies in comorbid patients with hypertension and dyslipidemia: the role of fixed-dose combinations by A. A. Sokolova, D. A. Napalkov

    Published 2023-12-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY

    NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY by D. A. Napalkov, A. A. Sokolova

    Published 2015-09-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease

    Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease by I. S. Daabul, A. A. Sokolova, D. A. Napalkov

    Published 2016-11-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS

    COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS by V. A. Sulimov, D. A. Napalkov, A. A. Sokolova

    Published 2015-09-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Rivaroxaban-Associated Hepatotoxicity: a Clinical Case and Literature Review

    Rivaroxaban-Associated Hepatotoxicity: a Clinical Case and Literature Review by B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov

    Published 2019-11-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION?

    ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? by D. A. Napalkov, A. A. Sokolova, A. V. Rodionov

    Published 2016-05-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE

    INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE by E. N. Golovenko, D. A. Napalkov, V. A. Sulimov

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants

    Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants by A. D. Aga, A. A. Sokolova, D. A. Napalkov

    Published 2023-01-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Metformin in metabolic syndrome treatment

    Metformin in metabolic syndrome treatment by V. I. Podzolkov, D. A. Napalkov, V. I. Makolkin

    Published 2005-06-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    The Risk of Myocardial Infarction in Patients with Atrial Fibrillation Taking a Direct Thrombin Inhibitor: Myths and Reality

    The Risk of Myocardial Infarction in Patients with Atrial Fibrillation Taking a Direct Thrombin Inhibitor: Myths and Reality by B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov

    Published 2020-05-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: